Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study (EndoDev)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02128139|
Recruitment Status : Unknown
Verified April 2014 by Institut National de la Santé Et de la Recherche Médicale, France.
Recruitment status was: Not yet recruiting
First Posted : May 1, 2014
Last Update Posted : May 1, 2014
Introduction. Comprehensive data on infective endocarditis in developing countries are scarce.
Objectives: Description of the characteristics (clinical and microbiological) and assessment of the outcomes of infective endocarditis in low-income countries.
Methods : Prospective, Observational, Multicentre study. Inclusion criteria: patients aged over 1 year fulfilling the modified Duke criteria for infective endocarditis.
Exclusion criteria: patient included during a previous infective endocarditis episode.
Outcomes measures: Mortality at 6 months follow-up; mortality at 1 month follow-up; access to antibiotic treatment (modalities and duration), hospital length of stay and reason for discharge, and cardiac surgery when indicated.
Duration: One year (June 2014- June 2015)
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study|
|Study Start Date :||June 2014|
|Estimated Primary Completion Date :||June 2015|
|Estimated Study Completion Date :||June 2015|
- Mortality at 1 month follow-up [ Time Frame: 1 month ]
- Mortality at 6 months follow-up [ Time Frame: 6 months ]
- Access to cardiac surgery [ Time Frame: 6 months ]Heart surgery is not available in many low-income countries. One of the objectives is to assess whether guidelines can be applied in low-secourced settings.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02128139
|Contact: Mariana S Mirabel, MDemail@example.com|
|Contact: Eloi Marijon, MDfirstname.lastname@example.org|
|Lao People's Democratic Republic|
|Paul N. Newton|
|Vientiane, Lao People's Democratic Republic|
|Contact: Paul N Newton, MD email@example.com|